Dr. Charles H. Redfern
Claim this profileSharp Memorial Hospital
Area of expertise
Cancer
Charles H. Redfern has run 4 trials for Cancer. Some of their research focus areas include:
Brain Cancer
Charles H. Redfern has run 3 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Sharp Memorial Hospital
Sharp HealthCare
Clinical Trials Charles H. Redfern is currently running
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
Encorafenib/Binimetinib/Nivolumab vs Ipilimumab/Nivolumab
for Melanoma
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Recruiting
1 award
Phase 2
23 criteria
More about Charles H. Redfern
Clinical Trial Related
9 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Charles H. Redfern has experience with
- Nivolumab
- Ipilimumab
- Xcellerated T CellsTM
- Pritumumab
- LHRH Analogue
- Abiraterone Acetate
Breakdown of trials Charles H. Redfern has run
Cancer
Brain Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles H. Redfern specialize in?
Charles H. Redfern focuses on Cancer and Brain Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Charles H. Redfern currently recruiting for clinical trials?
Yes, Charles H. Redfern is currently recruiting for 2 clinical trials in San Diego California. If you're interested in participating, you should apply.
Are there any treatments that Charles H. Redfern has studied deeply?
Yes, Charles H. Redfern has studied treatments such as Nivolumab, Ipilimumab, Xcellerated T CellsTM.
What is the best way to schedule an appointment with Charles H. Redfern?
Apply for one of the trials that Charles H. Redfern is conducting.
What is the office address of Charles H. Redfern?
The office of Charles H. Redfern is located at: Sharp Memorial Hospital, San Diego, California 92123 United States. This is the address for their practice at the Sharp Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.